Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRODEO prophylactic haloperidol trial for postoperative delirium prevention
NL-OMON45531Completed
- Sponsor
- Zuyderland
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in delirium comparing Haloperidol prophylaxis with Placebo control (2 arms). Primary endpoint: Delirium incidence within maximal 5 days after admission. Started Jul 2017; status: completed.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON45531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45531.